Simcere Pharmaceutical Group – Product Pipeline Review

Global Markets Direct’s, ‘Simcere Pharmaceutical Group – Product Pipeline Review – 2016’, provides an overview of the Simcere Pharmaceutical Group’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Simcere Pharmaceutical Group, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

The report provides a snapshot of the pipeline therapeutic landscape of Simcere Pharmaceutical Group

The report provides overview of Simcere Pharmaceutical Group including its business description, key facts, and locations and subsidiaries

The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

The report assesses Simcere Pharmaceutical Group’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

The report features Simcere Pharmaceutical Group’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

Evaluate Simcere Pharmaceutical Group’s strategic position with total access to detailed information on its product pipeline

Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of therapeutics under development for Simcere Pharmaceutical Group

Identify potential new clients or partners in the target demographic

Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics

Devise corrective measures for pipeline projects by understanding Simcere Pharmaceutical Group’s pipeline depth and focus of pipeline therapeutics

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents

Table of Contents

Table of Contents 2

List of Tables 5

List of Figures 5

Simcere Pharmaceutical Group Snapshot 6

Simcere Pharmaceutical Group Overview 6

Key Information 6

Key Facts 6

Simcere Pharmaceutical Group - Research and Development Overview 7

Key Therapeutic Areas 7

Simcere Pharmaceutical Group - Pipeline Review 10

Pipeline Products by Stage of Development 10

Pipeline Products - Monotherapy 11

Pipeline Products - Combination Treatment Modalities 12

Pipeline Products - Partnered Products 13

Partnered Products/Combination Treatment Modalities 14

Simcere Pharmaceutical Group - Pipeline Products Glance 15

Simcere Pharmaceutical Group - Late Stage Pipeline Products 15

Phase III Products/Combination Treatment Modalities 15

Simcere Pharmaceutical Group - Clinical Stage Pipeline Products 16

Phase II Products/Combination Treatment Modalities 16

Phase I Products/Combination Treatment Modalities 17

Simcere Pharmaceutical Group - Early Stage Pipeline Products 18

IND/CTA Filed Products/Combination Treatment Modalities 18

Preclinical Products/Combination Treatment Modalities 19

Discovery Products/Combination Treatment Modalities 20

Simcere Pharmaceutical Group - Drug Profiles 21

SIM-071201 21

Product Description 21

Mechanism of Action 21

R&D Progress 21

bendamustine hydrochloride 22

Product Description 22

Mechanism of Action 22

R&D Progress 22

(amlodipine besylate + irbesartan) 23

Product Description 23

Mechanism of Action 23

R&D Progress 23

APX-003 24

Product Description 24

Mechanism of Action 24

R&D Progress 24

metatinib tromethamine 25

Product Description 25

Mechanism of Action 25

R&D Progress 25

abatacept 26

Product Description 26

Mechanism of Action 26

R&D Progress 26

BMS-817378 29

Product Description 29

Mechanism of Action 29

R&D Progress 29

OSI-930 30

Product Description 30

Mechanism of Action 30

R&D Progress 30

SIM-010603 31

Product Description 31

Mechanism of Action 31

R&D Progress 31

SIM-0710 32

Product Description 32

Mechanism of Action 32

R&D Progress 32

BMS-795311 33

Product Description 33

Mechanism of Action 33

R&D Progress 33

SCR-1693 34

Product Description 34

Mechanism of Action 34

R&D Progress 34

SIM-89 35

Product Description 35

Mechanism of Action 35

R&D Progress 35

Small Molecule to Inhibit Bruton's Tyrosine Kinase for Arthritis 36

Product Description 36

Mechanism of Action 36

R&D Progress 36

Small Molecule for Cancer 37

Product Description 37

Mechanism of Action 37

R&D Progress 37

Simcere Pharmaceutical Group - Pipeline Analysis 38

Simcere Pharmaceutical Group - Pipeline Products by Target 38

Simcere Pharmaceutical Group - Pipeline Products by Route of Administration 40

Simcere Pharmaceutical Group - Pipeline Products by Molecule Type 41

Simcere Pharmaceutical Group - Pipeline Products by Mechanism of Action 42

Simcere Pharmaceutical Group - Recent Pipeline Updates 44

Simcere Pharmaceutical Group - Dormant Projects 49

Simcere Pharmaceutical Group - Locations And Subsidiaries 50

Head Office 50

Other Locations & Subsidiaries 50

Appendix 52

Methodology 52

Coverage 52

Secondary Research 52

Primary Research 52

Expert Panel Validation 52

Contact Us 52

Disclaimer 53

List of Tables

List of Tables

Simcere Pharmaceutical Group, Key Information 6

Simcere Pharmaceutical Group, Key Facts 6

Simcere Pharmaceutical Group – Pipeline by Indication, 2016 8

Simcere Pharmaceutical Group – Pipeline by Stage of Development, 2016 10

Simcere Pharmaceutical Group – Monotherapy Products in Pipeline, 2016 11

Simcere Pharmaceutical Group – Combination Treatment Modalities in Pipeline, 2016 12

Simcere Pharmaceutical Group – Partnered Products in Pipeline, 2016 13

Simcere Pharmaceutical Group – Partnered Products/ Combination Treatment Modalities, 2016 14

Simcere Pharmaceutical Group – Phase III, 2016 15

Simcere Pharmaceutical Group – Phase II, 2016 16

Simcere Pharmaceutical Group – Phase I, 2016 17

Simcere Pharmaceutical Group – IND/CTA Filed, 2016 18

Simcere Pharmaceutical Group – Preclinical, 2016 19

Simcere Pharmaceutical Group – Discovery, 2016 20

Simcere Pharmaceutical Group – Pipeline by Target, 2016 38

Simcere Pharmaceutical Group – Pipeline by Route of Administration, 2016 40

Simcere Pharmaceutical Group – Pipeline by Molecule Type, 2016 41

Simcere Pharmaceutical Group – Pipeline Products by Mechanism of Action, 2016 43

Simcere Pharmaceutical Group – Recent Pipeline Updates, 2016 44

Simcere Pharmaceutical Group – Dormant Developmental Projects,2016 49

Simcere Pharmaceutical Group, Subsidiaries 50

List of Figures

List of Figures

Simcere Pharmaceutical Group – Pipeline by Top 10 Indication, 2016 8

Simcere Pharmaceutical Group – Pipeline by Stage of Development, 2016 10

Simcere Pharmaceutical Group – Monotherapy Products in Pipeline, 2016 11

Simcere Pharmaceutical Group – Partnered Products in Pipeline, 2016 13

Simcere Pharmaceutical Group – Pipeline by Top 10 Target, 2016 38

Simcere Pharmaceutical Group – Pipeline by Route of Administration, 2016 40

Simcere Pharmaceutical Group – Pipeline by Molecule Type, 2016 41

Simcere Pharmaceutical Group – Pipeline Products by Top 10 Mechanism of Action, 2016 42

    Pricing

Discounts available for multiple purchases.

reportstore@globalmarketsdirect.com
+44 20 7947 2745

Saved reports